Beta-Thromboglobulin and Platelet Factor 4 in Patients with Myeloproliferative Diseases - Reply

• References

• 1 Fabris F, Luzzatto G, Randi ML, Celia G. Beta-thromboglobulin and platelet factor 4 in patients with myeloproliferative diseases. Thromb Haemost 1994; 72: 484-485
• 2 Bellucci S, Ignatova E, Jaillet N, Boffa MC. Platelet hyperactivation in patients with essential thrombocythemia is not associated with vascular endothelial cell damage as judged by the level of plasma thrombomodulin, protein S, PAI-1, t-PA and vWF. Thromb Haemost 1993; 70: 736-742
• 3 Files JC, Malpass TW, Yee EK, Ritchie JL, Harker LA. Studies of human platelet a-granule release in vivo. Blood 1981; 58: 607-618
• 4 Kerry PJ, Curtis AD. Standardization of β-thromboglobulin (β-TG) and platelet factor 4 (PF4): a collaborative study to establish international standards for β-TG and PF4. Thromb Haemost 1985; 53: 51-55
• 5 Randi ML, Fabris F, Casonato A, Girolami A. The effect of anticoagulant mixtures on β-TG and PF4 levels. Thromb Haemost 1981; 46: 569
• 6 Viero P, Cortelazzo S, Barbui T. Does the β-TG/PF4 ratio have any value in myeloproliferative diseases. Thromb Haemost 1984; 51: 411
• 7 Kaplan KL, Broekman MJ, Chemoff A, Lesznik GR, Drillings M. Platelet a-granule proteins: studies on release and subcellular localization. Blood 1979; 53: 604-618
• 8 Legrand C, Bellucci S, Disdier M, Edelman L, Tobelem G. Platelet throm-bospondin and glycoprotein IV abnormalities in patients with essential thrombocythemia. Effect of α-interferon treatment. Am J Hematol 1991; 38: 307-313
• 9 Kaplan KL, Owen J. Plasma levels of βthromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
• 10 Boughton J, Allington MJ, King A. Platelet and plasma ²thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis. Br J Haematol 1978; 40: 125-132